Urinary excretion of three nucleic acid oxidation adducts and isoprostane F2α measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers

Free Radical Biology and Medicine

Volumn 35, Issue 10, 2003, Pages 1301-1309

  Harman, S Mitchell ^a   Liang, Lynn ^b   Tsitouras, Panayiotis D ^a   Gucciardo, Frank ^a   Heward, Christopher B ^b   Reaven, Peter D ^c   Ping, Wei ^b   Ahmed, Alaa ^b   Cutler, Richard G ^a  

^a Kronos Longevity Research Institute   (United States)

^b Kronos Science Laboratory   (United States)

^c CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

Free radicals; Isoprostanes; Nucleic acids; Oxidative stress; Smoking

Indexed keywords

5 HYDROXYMETHYLDEOXYURIDINE; 8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; CREATININE; LIPID; NUCLEIC ACID; TOBACCO SMOKE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DNA ADDUCT; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SMOKING; URINARY EXCRETION;

NICOTIANA TABACUM;

EID: 0242321024     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.07.003     Document Type: Article

References (50)

1. Sohal R.S., Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 273:(5271):1996;59-63.
2. Cutler, R. G. Oxidative stress state in aging and longevity mechanisms. In: Poli, G., ed. Free radicals: from basic science to medicine. New York: Birkhauser Press; 1993:144-156.
3. Spector A. Review oxidative stress and disease . J. Ocul. Pharmacol. Ther. 16:2000;193-201.
4. Sohal R.S., Ku H.H., Agarwal S., Forster M.J., Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech. Ageing Dev. 74:1994;121-133.
5. Wallace D.C. A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found. Symp. 235:2001;247-263.
6. Loft S., Poulsen H.E. Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim. Pol. 45:1998;133-144.
7. England T., Beatty E., Rehman A., Nourooz-Zadeh J., Pereira P., O'Reilly J., Wiseman H., Geissler C., Halliwell B. The steady-state levels of oxidative DNA damage and of lipid peroxidation (F2-isoprostanes) are not correlated in healthy human subjects. Free Radic. Res. 32:2000;355-362.
8. Roberts L.J. II, Morrow J.D. The isoprostanes novel markers of lipid peroxidation and potential mediators of oxidant injury . Adv. Prostaglandin Thromboxane Leukot. Res. 23:1995;219-224.
9. Pratico D. F(2)-isoprostanes sensitive and specific non-invasive indices of lipid peroxidation in vivo . Atherosclerosis. 147:1999;1-10.
10. Poulsen H.E., Loft S., Prieme H., Vistisen K., Lykkesfeldt J., Nyyssonen K., Salonen J.T. Oxidative DNA damage in vivo relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion . Free Radic. Res. 29:1998;565-571.
11. Roberts L.J., Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic. Biol. Med. 28:2000;505-513.
12. Gopaul N.K., Halliwell B., Anggard E.E. Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Radic. Res. 33:2000;115-127.
13. Liang Y., Wei P., Duke R.W., Reaven P.D., Harman S.M., Cutler R.G., Heward C.B. Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic. Biol. Med. 34:2003;409-418.
14. Schisterman E.F., Faraggi D., Browne R., Freudenheim J., Dorn J., Muti P., Armstrong D., Reiser B., Trevisan M. TBARS and cardiovascular disease in a population-based sample. J. Cardiovasc. Risk. 8:2001;219-225.
15. Li D., Zhang W., Zhu J., Chang P., Sahin A., Singletary E., Bondy M., Hazra T., Mitra S., Lau S.S., Shen J., DiGiovanni J. Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol. Carcinog. 31:2001;214-223.
16. Terry P., Lagergren J., Ye W., Nyren O., Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int. J. Cancer. 87:2000;750-754.
17. Schapira A.H. Causes of neuronal death in Parkinson's disease. Adv. Neurol. 86:2001;155-162.
18. Montine T.J., Markesbery W.R., Zackert W., Sanchez S.C., Roberts L.J. II, Morrow J.D. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Am. J. Pathol. 155:1999;863-868.
19. Sayre L.M., Smith M.A., Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8:2001;721-738.
20. VanderJagt D.J., Harrison J.M., Ratliff D.M., Hunsaker L.A., VanderJagt D.L. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin. Biochem. 34:2001;265-270.
21. Halliwell B. Effect of diet on cancer development is oxidative DNA damage a biomarker? Free Radic. Biol. Med. 32:2002;968-974.
22. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:(20):1993;1444-1449.
23. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N. Engl. J. Med. 330(15):1029-1035; 1994.
24. Greenberg E.R., Baron J.A., Tosteson T.D., Freeman D.H. Jr., Beck G.J., Bond J.H., Colacchio T.A., Coller J.A., Frankl H.D., Haile R.W., et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N. Engl. J. Med. 331:(3):1994;141-147.
25. Loft S., Poulsen H.E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74:1996;297-312.
26. Asami S., Manabe H., Miyake J., Tsurudome Y., Hirano T., Yamaguchi R., Itoh H., Kasai H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis. 18:1997;1763-1766.
27. Church D.F., Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect. 64:1985;111-126.
28. Vayssier-Taussat M., Camilli T., Aron Y., Meplan C., Hainaut P., Polla B.S., Weksler B. Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H1293-1300.
29. Kaplan M., Aviram M. Oxidized low density lipoprotein atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase . Clin. Chem. Lab. Med. 37:1999;777-787.
30. Krupski W.C. The peripheral vascular consequences of smoking. Ann. Vasc. Surg. 5:1991;291-304.
31. Sakkinen P., Abbott R.D., Curb J.D., Rodriguez B.L., Yano K., Tracy R.P. C-reactive protein and myocardial infarction. J. Clin. Epidemiol. 55:2002;445-451.
32. Scheffler E., Wiest E., Woehrle J., Otto I., Schulz I., Huber L., Ziegler R., Dresel H.A. Smoking influences the atherogenic potential of low-density lipoprotein. Clin. Investig. 70:1992;263-268.
33. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963-20966.
34. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking 40 years' observations on male British doctors . BMJ. 309:(6959):1994;901-911.
35. Shigenaga M.K., Gimeno C.J., Ames B.N. Urinary 8-hydroxy-2′- deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. USA. 86:1989;9697-9701.
36. Loft S., Larsen P.N., Rasmussen A., Fischer-Nielsen A., Bondesen S., Kirkegaard P., Rasmussen L.S., Ejlersen E., Tornoe K., Bergholdt R., et al. Oxidative DNA damage after transplantation of the liver and small intestine in pigs. Transplantation. 59:1995;16-20.
37. Jaruga P., Zastawny T.H., Skokowski J., Dizdaroglu M., Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett. 341:1994;59-64.
38. Mooney L.A., Perera F.P., Van Bennekum A.M., Blaner W.S., Karkoszka J., Covey L., Hsu Y., Cooper T.B., Frenkel K. Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol. Biomarkers Prev. 10:2001;641-648.
39. Frenkel K., Karkoszka J., Glassman T., Dubin N., Toniolo P., Taioli E., Mooney L.A., Kato I. Serum autoantibodies recognizing 5-hydroxymethyl-2′- deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women. Cancer Epidemiol. Biomarkers Prev. 7:1998;49-57.
40. Awad J.A., Morrow J.D., Takahashi K., Roberts L.J. II. Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J. Biol. Chem. 268:1993;4161-4169.
41. Morrow J.D., Minton T.A., Mukundan C.R., Campbell M.D., Zackert W.E., Daniel V.C., Badr K.F., Blair I.A., Roberts L.J. II. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269:1994;4317-4326.
42. Loft S., Vistisen K., Ewertz M., Tjonneland A., Overvad K., Poulsen H.E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans influence of smoking, gender and body mass index . Carcinogenesis. 13:1992;2241-2247.
43. Prieme H., Loft S., Klarlund M., Gronbaek K., Tonnesen P., Poulsen H.E. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion. Carcinogenesis. 19:1998;347-351.
44. Keaney J.F. Jr., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J. Obesity and systemic oxidative stress clinical correlates of oxidative stress in the Framingham Study . Arterioscler. Thromb. Vasc. Biol. 23:2003;434-439.
45. Dietrich M., Block G., Hudes M., Morrow J.D., Norkus E.P., Traber M.G., Cross C.E., Packer L. Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. Cancer Epidemiol. Biomarkers Prev. 11:2002;7-13.
46. Pilz H., Oguogho A., Chehne F., Lupattelli G., Palumbo B., Sinzinger H. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb. Res. 99:2000;209-221.
47. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 94:1996;19-25.
48. Crook M.A., Scott D.A., Stapleton J.A., Palmer R.M., Wilson R.F., Sutherland G. Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. Eur. J. Clin. Invest. 30:2000;861-865.
49. Kiechl S., Werner P., Egger G., Oberhollenzer F., Mayr M., Xu Q., Poewe W., Willeit J. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis prospective results from the Bruneck Study . Stroke. 33:2002;2170-2176.
50. Basu S., Whiteman M., Mattey D.L., Halliwell B. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. Ann. Rheum. Dis. 60:2001;627-631.